1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow IGM-2644: new trials by email Literature Review of IGM-2644 trials Research Report on IGM-2644
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma IGM-2644 - Multiple Myeloma | Phase 1 | Terminated | IGM Biosciences, Inc. | 4 | 2023-08-29 | 2024-08-01 |
Multiple Myeloma (1)
United States (1)